These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Add-on effect of bedtime dosing of the alpha(1)-adrenergic receptor antagonist doxazosin on morning hypertension and left ventricular hypertrophy in patients undergoing long-term amlodipine monotherapy. Ikeda T; Gomi T; Shibuya Y; Shinozaki S; Suzuki Y; Matsuda N Hypertens Res; 2007 Nov; 30(11):1097-105. PubMed ID: 18250559 [TBL] [Abstract][Full Text] [Related]
13. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment]. Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737 [TBL] [Abstract][Full Text] [Related]
14. Metabolic and cardiovascular characteristics of hypertension. Familial aspects. Neutel JM; Smith DH Cardiol Clin; 1995 Nov; 13(4):539-47. PubMed ID: 8565017 [TBL] [Abstract][Full Text] [Related]
15. Influence of multiple risk factors on the hazard of hypertension. Kannel WB J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S53-7. PubMed ID: 11527137 [TBL] [Abstract][Full Text] [Related]
16. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy and reduction in sudden cardiac death: the LIFE Study. Wachtell K; Okin PM; Olsen MH; Dahlöf B; Devereux RB; Ibsen H; Kjeldsen SE; Lindholm LH; Nieminen MS; Thygesen K Circulation; 2007 Aug; 116(7):700-5. PubMed ID: 17664372 [TBL] [Abstract][Full Text] [Related]
17. [Renal and cardiac effects of chronic doxazosin therapy in patients with essential arterial hypertension]. Bignotti M; Lamponi M Minerva Cardioangiol; 1996 Jun; 44(6):331-5. PubMed ID: 8927264 [TBL] [Abstract][Full Text] [Related]
18. [Reducing blood pressure and modification of coronary risk factors by therapy with doxazosin]. Hitzenberger G; Ganzinger U Wien Klin Wochenschr; 1993; 105(13):371-6. PubMed ID: 8351927 [TBL] [Abstract][Full Text] [Related]
19. Coronary disease in hypertension: a new mosaic. Julius S J Hypertens Suppl; 1997 Mar; 15(2):S3-10. PubMed ID: 9218191 [TBL] [Abstract][Full Text] [Related]
20. Alpha 1 blockers: antihypertensives whose positive metabolic profile with regard to hyperinsulinaemia and lipid metabolism cannot be ignored. Waite MA J Intern Med Suppl; 1991; 735():113-7. PubMed ID: 1675053 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]